UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 4, 2009
_______________________________________________________________________
LEE ENTERPRISES, INCORPORATED
(Exact name of Registrant as specified in its charter)
_______________________________________________________________________
Commission File Number 1-6227
Delaware (State of Incorporation) | 42-0823980 (I.R.S. Employer Identification No.) |
201 N. Harrison Street, Davenport, Iowa 52801
(Address of Principal Executive Offices)
(563) 383-2100
Registrant’s telephone number, including area code
_____________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. | Other Events. |
On September 4, 2009, Lee Enterprises, Incorporated (the “Company”) was notified by the New York Stock Exchange that its share price has risen to a sufficient level to cure a share price deficiency. Therefore, the Company has returned to compliance with the exchange’s continued listing requirements for share price. The NYSE had notified Lee in December 2008 that the Company was not in compliance with the exchange's continued listing standard that requires an average closing price of at least $1.00 per share of its publicly traded common shares over a 30-trading day period. At the time, the NYSE's rules granted the Company a six-month period within which to cure the price deficiency. Since then, the NYSE temporarily suspended the standard through July 31, 2009, and, as a result, extended Company's six-month cure period until December 3, 2009.
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| LEE ENTERPRISES, INCORPORATED
|
|
|
|
|
| |
Date: September 11, 2009
| By: | |
|
| Carl G. Schmidt |
|
| Vice President, Chief Financial Officer, |
|
| and Treasurer |
